Biosite Announces Presentation at the Thomas Weisel Partners 2006 Healthcare Conference
September 01 2006 - 1:02PM
PR Newswire (US)
SAN DIEGO, Sept. 1 /PRNewswire-FirstCall/ -- Biosite Incorporated
(NASDAQ:BSTE) today announced that Kim Blickenstaff, chairman and
chief executive officer, and Ken Buechler, Ph.D., president and
chief scientific officer, will discuss the Company's operating
environment, products and research and development activities at
the Thomas Weisel Partners 2006 Healthcare Conference. The
conference will be held at the Four Seasons Hotel in Boston.
Biosite's presentation will take place September 8, 2006, at 8:35
a.m. Eastern Daylight Time. A link to the live audio webcast can be
accessed through the Biosite website, http://www.biosite.com/. The
Biosite presentation will be archived on the website until
September 29, 2006 in the Investor Center under Events Calendar.
About Biosite Incorporated Biosite Incorporated is a leading
bio-medical company commercializing proteomics discoveries for the
advancement of medical diagnosis. The Company's products contribute
to improvements in medical care by aiding physicians in the
diagnosis of critical diseases and health conditions. Biosite's
Triage(R) rapid diagnostics are used in approximately 50 percent of
U.S. hospitals and in more than 60 international markets.
Information on Biosite can be found at http://www.biosite.com/.
Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are
registered trademarks of Biosite Incorporated. The Company's logo
is a trademark of Biosite Incorporated. DATASOURCE: Biosite
Incorporated CONTACT: Nadine Padilla, Vice President, Corporate and
Investor Relations of Biosite Incorporated, +1-858-805-2820, Web
site: http://www.biosite.com/ Company News On-Call:
http://www.prnewswire.com/comp/116737.html
Copyright
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jul 2023 to Jul 2024